how many people use semaglutide The FDA approved Wegovy HD (semaglutide 7.2 mg) today. Here's the clinical context every obesity medicine provider needs. The STEP UP trial delivered 20.7% mean weight loss at 72 weeks in ADA 2026 - High-dose subcutaneous

In that case, its important to consult your healthcare provider

Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

If injecting into your belly, stay at least two inches away from your belly button

Muscle Aches: Persistent pain and discomfort in muscles

Fiona Gribble (University of Cambridge, UK)

Tirzepatide: A Dual GLP-1 and GIP Agonist Tirzepatide, on the other hand, is a dual agonist , meaning it mimics the action of two natural gut hormones: GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide)